Infective larvae (L3) of the human filarial parasite Brugia malayi are rapi
dly eliminated from immunocompetent mice, while in nude as well as SCID mic
e they develop into mature adult parasites. We now report our attempts to i
nfect mice with X-linked immunodeficiency with larval stages of B. malayi.
CBA/N strain of mice have an XID mutation that renders them deficient in pr
oducing of antibodies to T-independent antigens such as polysaccharides whi
le they respond normally to protein antigens. Groups of deficient (CBA/N) a
s well as normal mice (CBA/CaJ) were infected with L3 stages of B. malayi.
About 8 % of the larvae developed into juvenile adults by 45 - 50 days post
infection in CBA/N mice while only 0.75 % of worms could be recovered from
+/+ mice. There was no significant growth or development of parasites beyon
d 50 days in CBA/N mice. On the contrary, worm recovery decreased progressi
vely in CBA/N mice after 50 days. Only about 2.6 % and 1.25 % of the worms
could be recovered by 90 and 120 days post-infection in CBA/N mice. There w
as no significant difference between the two strains of mice in antibody le
vels to soluble adult worm antigens, nor in their ability to make antibodie
s to the surface of the developing larvae. We propose the use of CBA/N mice
for studies on the development of protective immunity to larval stages of
the human filarial parasite and for screening potential anti-larval drugs.
Med Sci Res 27:135-137 (C) 1999 Lippincott Williams & Wilkins.